PURR
$6.05
Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was incorporated in 2025 and is based in New York, New York.
Recent News
Hyperliquid Strategies Q2 Earnings Call Highlights
Hyperliquid Strategies (NASDAQ:PURR) executives used the company’s second fiscal quarter earnings call to reiterate that the firm operates as a digital asset treasury company focused on holding the HYPE token, while outlining recent capital deployment activity, a financial loss driven largely by tok
Nasdaq-Listed Hyperliquid DAT Announces Purchase of $25 Million Worth of HYPE Tokens
Hyperliquid StrategiesHYPE token purchasePURR stock priceHyperliquid earnings Q4 2025crypto treasury companies
KB Home downgraded, Costco upgraded: Wall Street's top analyst calls
KB Home downgraded, Costco upgraded: Wall Street's top analyst calls
KB Home downgrade, Costco upgraded: Wall Street's top analyst calls
KB Home downgrade, Costco upgraded: Wall Street's top analyst calls